Tema Oncology ETF

Yield per half year: -12.19%
Industry: Health & Biotech Equities

Regeneron
AstraZeneca PLC
Merck & Co
argenx SE
Daiichi Sankyo Company, Limited
Amgen
Chugai Pharmaceutical Co., Ltd.
Blueprint Medicines Corporation
Illumina
Revolution Medicines, Inc.
Other
Regeneron: 6.1%AstraZeneca PLC: 5.9%Merck & Co: 4.3%argenx SE: 4.2%Daiichi Sankyo Company, Limited: 3.8%Amgen: 3.8%Chugai Pharmaceutical Co., Ltd.: 3.6%Blueprint Medicines Corporation: 3.3%Illumina: 3.3%Revolution Medicines, Inc.: 3.1%Other: 58.7%Share share by companyen.porti.ru
Download SVG
Download PNG
Download CSV
TitleIndustryShare, %P/BVP/SP/EEV/EbitdaDividend yield
Regeneron Regeneron Healthcare 6.0665 3.71 7.34 24.35 23.78 0.1388
AstraZeneca PLC AstraZeneca PLC Healthcare 5.94354 2.49 1.88 14.45 7.38 1.98
Merck & Co Merck & Co Healthcare 4.26457 7.29 4.56 751.54 40.3 2.82
argenx SE argenx SE Healthcare 4.19048 5.2 17.38 0 -87.37 0
Daiichi Sankyo Company, Limited Daiichi Sankyo Company, Limited Healthcare 3.81885 5.48 5.78 46.09 29.44 1.54
Amgen Amgen Healthcare 3.775 24.53 5.42 22.76 26.16 2.92
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. Healthcare 3.57457 5.41 7.92 27.04 18.68 2.06
Blueprint Medicines Corporation Blueprint Medicines Corporation Healthcare 3.30318 41.19 21.57 15.98 -12.82 0
Illumina Illumina Healthcare 3.27465 3.85 4.86 39.92 -21.83 0
Revolution Medicines, Inc. Revolution Medicines, Inc. Healthcare 3.12948 1.79 282.39 0 -5.57 0
41.3210.0935.9194.211.811.15

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription